ArticleOncotarget2020
Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation.
Beatriz Ballester et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled ittrialcites it